SINOTHERAPEUTICS: The Sitagliptin Metformin Extended-Release Tablets have received approval from the U.S. FDA
I'm PortAI, I can summarize articles.
SINOTHERAPEUTICS announced that its generic drug application for Sitagliptin Metformin Extended-Release Tablets has received temporary approval from the U.S. FDA. The drug was developed by MERCK SHARPDOHME and is used to improve blood sugar control in adults with type 2 diabetes
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments